Literature DB >> 2428264

Meningiomas. Diagnostic value of immunoperoxidase staining for epithelial membrane antigen.

S J Schnitt, H Vogel.   

Abstract

Meningiomas are composed of cells which display both mesenchymal and epithelial features. To investigate the epithelial nature of these cells, we studied the distribution of epithelial membrane antigen (EMA) in 22 meningiomas; for comparison, we also studied eight central schwannomas, neoplasms with which meningiomas sometimes may be confused histologically. All 22 meningiomas (12 transitional, six meningotheliomatous, three fibroblastic, and one psammomatous) demonstrated immunoreactive EMA, whereas all eight schwannomas were EMA-negative. There was no consistent relationship between histologic growth pattern and nature of EMA staining in the meningiomas: meningothelial areas, spindle cell areas, and whorls all showed EMA immunoreactivity of varying degrees. We also evaluated the distribution of S-100 protein and keratin in these tumors. All schwannomas showed diffuse S-100 positivity, which was often more intense in the nuclei than in the cytoplasm. In nine meningiomas (41%), S-100 immunostaining was observed, but this was usually focal, and nuclear staining was never more intense than cytoplasmic staining. One meningioma, but none of the schwannomas, showed clusters of keratin-positive cells. We conclude the following: EMA immunoreactivity is a characteristic feature of meningiomas, regardless of pattern of growth, and the combination of immunoperoxidase staining for EMA and S-100 protein may be used to distinguish meningiomas from schwannomas in problematic cases.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2428264     DOI: 10.1097/00000478-198609000-00006

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  28 in total

Review 1.  Cervical lymph node metastases from remote primary tumor sites.

Authors:  Fernando López; Juan P Rodrigo; Carl E Silver; Missak Haigentz; Justin A Bishop; Primož Strojan; Dana M Hartl; Patrick J Bradley; William M Mendenhall; Carlos Suárez; Robert P Takes; Marc Hamoir; K Thomas Robbins; Ashok R Shaha; Jochen A Werner; Alessandra Rinaldo; Alfio Ferlito
Journal:  Head Neck       Date:  2015-12-29       Impact factor: 3.147

2.  Meningioangiomatosis: an immunocytochemical study.

Authors:  J J Goates; D W Dickson; D S Horoupian
Journal:  Acta Neuropathol       Date:  1991       Impact factor: 17.088

3.  Cellular schwannoma. A clinicopathologic study of 29 cases.

Authors:  P Lodding; L G Kindblom; L Angervall; G Stenman
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1990

4.  Microwave fixation provides excellent preservation of tissue, cells and antigens for light and electron microscopy.

Authors:  G R Login; A M Dvorak
Journal:  Histochem J       Date:  1988 Jun-Jul

5.  Primary intraosseous meningioma of the mandible: CT and MR imaging features.

Authors:  M Lell; C Tudor; T Aigner; P Kessler
Journal:  AJNR Am J Neuroradiol       Date:  2007-01       Impact factor: 3.825

6.  Do folliculo-stellate adenomas of the pituitary gland exist or are they intrasellar meningiomas?

Authors:  H Vogel; D S Horoupian; G Silverberg
Journal:  Acta Neuropathol       Date:  1988       Impact factor: 17.088

Review 7.  The biology and pathology of selected skull base tumors.

Authors:  L Barnes; S B Kapadia
Journal:  J Neurooncol       Date:  1994       Impact factor: 4.130

8.  Intraoral schwannoma in retromolar region.

Authors:  Sanjay Jadwani; Snehal Bansod; Biswajit Mishra
Journal:  J Maxillofac Oral Surg       Date:  2011-03-25

9.  Sclerosing fibrous tumor of the cauda equina: a fibroblastic variant of peripheral nerve tumors?

Authors:  M Hisaoka; A Furuta; S Rikimaru
Journal:  Acta Neuropathol       Date:  1993       Impact factor: 17.088

10.  Melanotic cerebral ganglioglioma: evidence for melanogenesis in neoplastic astrocytes.

Authors:  D Soffer; B Lach; S Constantini
Journal:  Acta Neuropathol       Date:  1992       Impact factor: 17.088

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.